Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmo …
maritime academy of toledo sebastian st cyr naval officer programs
No comments:
Post a Comment